Labcorp price target raised to $290 from $260 at Argus
Argus analyst David Toung raised the firm’s price target on Labcorp (LH) to $290 from $260 and keeps a Buy rating on the shares after its Q4 ...
Fortrea: A Growing CRO With Strong Backlog, Margin Expansion, And Industry Tailwinds
Discover how FTRE's $7.7B backlog, CRO market growth, and focus on high-margin areas ensure long-term growth, efficiency, and ...
Don't know if you got the measles vaccine? Just get another shot, doctors say
Texas doctors said there's no harm in getting another measles vaccine if you don't know whether you were vaccinated as a ...
Zacks Investment Research on MSN2d
Should Labcorp Stock Stay in Your Portfolio Right Now?
Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.
3 Reasons to Avoid LH and 1 Stock to Buy Instead
Labcorp has been a great trade, beating the S&P 500 by 6.9%. Its stock price has climbed to $255.01, representing a healthy ...
Asianet Newsable on MSN3d
Labcorp Gains Citi Upgrade While Quest Diagnostics Faces Downgrade On Margin Concerns — Retail Sentiment Mixed
A Wall Street analyst issued contrasting ratings on Tuesday for two major diagnostic testing companies, upgrading shares of ...
Car crashes into LabCorp storefront in Newton Plaza II, no injuries reported
A vehicle crashed into the LabCorp business at 595 Loudon Rd in Newton Plaza II on March 4, causing significant damage to the ...
Charles River, LabCorp upgraded, Quest downgraded at Citi on valuation
Charles River Labs (CRL) stock and LabCorp (LH) stock were upgraded and Quest Diagnostics (DGX) stock was downgraded at Citi.
QNS4d
Senator Joe Addabbo partners with Taxi and Limousine Commission to host Van Hailin’ resource event for drivers
Senator Addabbo is teaming up with the NYC Taxi and Limousine Commission (TLC) to host a valuable resource event for ...
Labcorp upgraded to Buy from Neutral at Citi
Citi upgraded Labcorp (LH) to Buy from Neutral with a price target of $300, up from $250. Utilization rates have been running high ...
Labcorp Holdings Inc. stock rises Friday, still underperforms market
Shares of Labcorp Holdings Inc. LH rose 1.31% to $251.04 Friday, on what proved to be an all-around positive trading session ...
TMCnet8d
ACCESS MEDICAL LABS CONFIRMS ELIZABETH HOLMES EXACT PFIZER STUDY RESULTS USING THE SAME COMPONENTS
In 2007 and 2008, Holmes conducted a study for Pfizer investigating the angiogenesis process and the effect of Bevacizumab, an anti-VEGF antibody therapy used in cancer treatment under the brand name, ...